THERAGENICS CORP·4

Mar 2, 2:51 PM ET

OBANNON MICHAEL 4

4 · THERAGENICS CORP · Filed Mar 2, 2009

Insider Transaction Report

Form 4
Period: 2009-02-26
OBANNON MICHAEL
Exc. VP Org. Dev.
Transactions
  • Award

    Theragenics Corporation common stock

    2009-02-26+8,00053,204 total
  • Award

    Theragenics Corporation common stock

    2009-02-26+4,11845,204 total
  • Award

    Stock Options (Right to Buy)

    2009-02-26+19,00096,000 total
    Exercise: $0.93Exp: 2019-02-26common stock (19,000 underlying)
Footnotes (6)
  • [F1]Represents the performance-based component of a performance restricted stock right. The filing person has previously reported 2,700 shares issuable under the time-based vesting component of performance restricted stock rights ("performance rights"). The performance-based vesting component of the performance rights were not deemed beneficially owned under Section 16.
  • [F2]Rights granted for no consideration.
  • [F3]Restricted Stock Award vesting 25% annually, commencing on 2/26/10.
  • [F4]Restricted stock grant for no consideration
  • [F5]Aggregate shares include common stock owned through the Theragenics Employee 401(K) Savings Plan and the Employee Stock Purchase Plan
  • [F6]Option Award exercisable at 25% annually, commencing on 2/26/10.

Documents

2 files
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY FOR MR. O'BANNON